1naresh
Array ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) ) 1nareshArray ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) )Table 3:Patient symptoms and indications for examinations in the 2 groups based on hypointense foci
Hypointense Foci (+) (n = 38) Hypointense Foci (−) (n = 21) n n % n % Symptoms or clinical indications for examinations No/follow-up of primary disease 11 52.4 10 47.6 21 Seizures 5 83.3 1 16.7 6 Transient ischemic attack/stroke 5 83.3 1 16.7 6 Dizziness, vertigo 1 25 3 75 4 Headache 4 100 0 0 4 Sensory disturbance 2 66.7 1 33.3 3 Double vision 2 100 0 0 2 Dysarthria 2 100 0 0 2 Nerve palsy 1 50 1 50 2 SDH 1 50 1 50 2 Consciousness disturbance 1 100 0 0 1 ICH 1 100 0 0 1 Visual field disturbance 1 100 0 0 1 SAH 0 0 1 100 1 Syncope 0 0 1 100 1 Trauma 0 0 1 100 1 Unknown 1 0 1
Note:—SDH indicates subdural hematoma.